Key result
Biological sex is a strong modulator of the clinical manifestation of cardiomyopathies, with sex-specific characteristics detectable in all classes.
Biological sex strongly modulates the clinical manifestation of cardiomyopathies, highlighting the need for clinicians to recognize sex-specific aspects for accurate diagnosis.
Sex differences may refine cardiomyopathy diagnosis; leaves open prospective validation of sex-adjusted criteria.
Cardiomyopathies are a heterogeneous group of heart muscle diseases with a variety of specific phenotypes. According to the contemporary European Society of Cardiology classification, they are classified into hypertrophic (HCM), dilated (DCM), arrhythmogenic right ventricular (ARVC), restrictive (RCM), and unclassified cardiomyopathies. Each class is aetiologically further categorized into inherited (familial) and non-inherited (non-familial) forms. There is substantial evidence that biological sex is a strong modulator of the clinical manifestation of these cardiomyopathies, and sex-specific characteristics are detectable in all classes. For the clinician, it is important to know the sex-specific aspects of clinical disease expression and the potential modes of inheritance or the hereditary influences underlying the development of cardiomyopathies, since these may aid in diagnosing such diseases in both sexes.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (2014) conducted a review in Cardiomyopathies. Biological sex was evaluated. Biological sex is a strong modulator of the clinical manifestation of cardiomyopathies, with sex-specific characteristics detectable in all classes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: